|

Resmetirom Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Naga P. Chalasani1

Indications

  • MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease1
  • HIV - Human Immunodeficiency Virus1
  • Liver Disease1

Birmingham, Alabama1 trial

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

University of Alabama Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.